First American Properties CEO Michael S. Eisenga provides insight on Latest JOLTS and BLS Labor Market Data

First American Properties CEO Michael S. Eisenga provides insight on Latest JOLTS and BLS Labor Market Data GlobeNewswire January 12, 2026 COLUMBUS, Wis., Jan. 12, 2026 (GLOBE NEWSWIRE) — Michael S. Eisenga, Chief Executive Officer of First American Properties, today issued the following statement in response to the most recent Job Openings and Labor Turnover […]

USE.com Announce Focus on Exchange Utility as Presale Gains Momentum

USE.com Announce Focus on Exchange Utility as Presale Gains Momentum GlobeNewswire January 12, 2026 DUBAI, United Arab Emirates, Jan. 12, 2026 (GLOBE NEWSWIRE) — USE.com has announced its ongoing presale with focus on exchange utility amid the current crypto market entry into a new phase marked by a renewed focus on infrastructure and utility. In

Deadline Alert: Blue Owl Capital Inc. (OWL) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

(NYSE:OWL), LOS ANGELES, Jan. 12, 2026 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming February 2, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) securities

Deadline Alert: Blue Owl Capital Inc. (OWL) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Deadline Alert: Blue Owl Capital Inc. (OWL) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit GlobeNewswire January 12, 2026 LOS ANGELES, Jan. 12, 2026 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming February 2, 2026 deadline to file a lead plaintiff motion

Matt Stang's Triumphant Return to High Times

New York, New York–(Newsfile Corp. – January 12, 2026) – Matt Stang, former High Times co-owner and Chief Revenue Officer, recently announced his return to the publication for its new era. Matthew Stang is partnering with HBI Innovations – independent distributor of the RAW brand of smoking accessories – founder Josh Kesselman for this venture.

Zenwise Unveils Rebrand, Redefining Gut Health as the Foundation of Everyday Wellness

Zenwise today announces the launch of its rebrand, positioning gut health not as a single supplement category, but as the foundation of everyday wellness. Built on a simple belief that when your gut feels good, you feel good, the gut-first supplement brand is setting a new standard for how gut health fits into modern life.

JAYUD GLOBAL LOGISTICS LIMITED (NASDAQ: JYD) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by January 20, 2026

National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against Jayud Global Logistics Limited (NASDAQ: JYD) (“Jayud” or the “Company”) on behalf of investors who purchased or otherwise acquired Jayud securities during the period of April 21, 2023 through April 30, 2025 (the “Class Period”), inclusive. Investor Deadline:

Zoomex Insights From BeInCrypto Reviews: What Transparency Means in Practice

Victoria, Seychelles–(Newsfile Corp. – January 12, 2026) – As transparency becomes a defining standard in crypto trading, platforms are increasingly judged on how clearly they handle asset custody, settlement, and withdrawals. For many traders, these factors now outweigh product complexity or promised returns. A recent BeInCrypto review examines Zoomex’s transparency-first approach, focusing on how the

Curasight Announces Encouraging Preliminary Data from Phase 1 Trial Evaluating First-in-Class Radiopharmaceutical uTREAT in High-Grade GliomasĀ®

— Clear uptake of uTREAT® in aggressive brain cancer (glioblastoma) — Early data support the potential of first-in-class uPAR-targeted theranostic approach to enable more specific diagnosis and more targeted treatment of high-grade gliomas and other uPAR expressing aggressive solid tumors Curasight A/S (“Curasight” or “the Company” – TICKER: CURAS), a clinical-stage radiopharmaceutical company developing first-in-class

Deadline Alert: F5, Inc. (FFIV) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

(NASDAQ:FFIV), LOS ANGELES, Jan. 12, 2026 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming February 17, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired F5, Inc. (“F5” or the “Company”) (NASDAQ: FFIV) securities between October 28,

Scroll to Top